PA
VTOL icon

PharVision Advisers’s Bristow Group VTOL Stock Holding History

PharVision Advisers’s Portfolio VTOL Stock Details VTOL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-5,933
Closed -$217K – 644
2025
Q4 		$217K Buy
+5,933
New +$223K 0.11% 490

Other funds holding VTOL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SAAM
Solus Alternative Asset Management Summit, New Jersey $372M AUM 45.33% 1-Year Est. Return
SDIC
South Dakota Investment Council Sioux Falls, South Dakota $5.24B AUM 22.1% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
ECP
Empyrean Capital Partners Los Angeles, California $3.07B AUM 34.24% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCA
Taconic Capital Advisors New York $229M AUM 110.07% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

PharVision Advisers's VTOL Position: Q1 2026 in Review

PharVision Advisers sold out of Bristow Group (VTOL) in Q1 2026, closing a stake of 5,933 shares — an estimated $217K sold.

PharVision Advisers first reported a position in VTOL in Q4 2025 and held it in 1 quarter. The position peaked at $217K in Q4 2025. 220 funds tracked by Wall St. Rank hold VTOL as of Q1 2026.

  • PharVision Advisers reported no remaining Bristow Group position as of Q1 2026 after selling out during the quarter.
  • PharVision Advisers sold 5,933 Bristow Group shares in Q1 2026, an estimated $217K.
  • PharVision Advisers first reported a position in Bristow Group in Q4 2025 and held it in 1 quarter.
  • PharVision Advisers's Bristow Group position peaked at $217K in Q4 2025.
  • 220 funds tracked by Wall St. Rank held Bristow Group as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.